| 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with … Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ... Ep Europace 17 (11), 1601-1687, 2015 | 5493 | 2015 |
| Dilated cardiomyopathy HP Schultheiss, DL Fairweather, ALP Caforio, F Escher, RE Hershberger, ... Nature reviews Disease primers 5 (1), 32, 2019 | 544 | 2019 |
| Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria D Corrado, MP Marra, A Zorzi, G Beffagna, A Cipriani, M De Lazzari, ... International journal of cardiology 319, 106-114, 2020 | 383 | 2020 |
| Long-term follow-up of patients with short QT syndrome C Giustetto, R Schimpf, A Mazzanti, C Scrocco, P Maury, O Anttonen, ... Journal of the American College of Cardiology 58 (6), 587-595, 2011 | 340 | 2011 |
| Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis D Corrado, PJ Van Tintelen, WJ McKenna, RNW Hauer, A Anastastakis, ... European heart journal 41 (14), 1414-1429, 2020 | 297 | 2020 |
| Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy ED Smith, NK Lakdawala, N Papoutsidakis, G Aubert, A Mazzanti, ... Circulation 141 (23), 1872-1884, 2020 | 286 | 2020 |
| Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis J Sroubek, V Probst, A Mazzanti, P Delise, JC Hevia, K Ohkubo, A Zorzi, ... Circulation 133 (7), 622-630, 2016 | 256 | 2016 |
| Novel insight into the natural history of short QT syndrome A Mazzanti, A Kanthan, N Monteforte, M Memmi, R Bloise, V Novelli, ... Journal of the American College of Cardiology 63 (13), 1300-1308, 2014 | 244 | 2014 |
| Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 A Mazzanti, R Maragna, A Faragli, N Monteforte, R Bloise, M Memmi, ... Journal of the American College of Cardiology 67 (9), 1053-1058, 2016 | 228 | 2016 |
| Arrhythmogenic right ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk A Mazzanti, K Ng, A Faragli, R Maragna, E Chiodaroli, N Orphanou, ... Journal of the American College of Cardiology 68 (23), 2540-2550, 2016 | 186 | 2016 |
| Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome A Mazzanti, R Maragna, G Vacanti, N Monteforte, R Bloise, M Marino, ... Journal of the American College of Cardiology 71 (15), 1663-1671, 2018 | 173 | 2018 |
| Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome N Lahrouchi, R Tadros, L Crotti, Y Mizusawa, PG Postema, L Beekman, ... Circulation 142 (4), 324-338, 2020 | 109 | 2020 |
| ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for … SG Priori, C Blomström-Lundqvist, A Mazzanti, N Blom, M Borggrefe, ... Eur Heart J 36 (41), 2793-2867, 2015 | 95 | 2015 |
| Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca SG Priori, C Blomström-Lundqvist, A Mazzanti, N Blom, M Borggrefe, ... Revista Española de Cardiología 69 (2), 2016 | 89* | 2016 |
| Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain D García-Giustiniani, M Arad, M Ortíz-Genga, R Barriales-Villa, ... Heart 101 (13), 1047-1053, 2015 | 81 | 2015 |
| The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases A Mazzanti, S O’Rourke, K Ng, C Miceli, G Borio, A Curcio, F Esposito, ... Expert review of cardiovascular therapy 12 (4), 499-519, 2014 | 78 | 2014 |
| Allele-specific silencing of mutant mRNA rescues ultrastructural and arrhythmic phenotype in mice carriers of the R4496C mutation in the ryanodine receptor gene (RYR2) R Bongianino, M Denegri, A Mazzanti, F Lodola, A Vollero, ... Circulation research 121 (5), 525-536, 2017 | 74 | 2017 |
| Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility J Barc, R Tadros, C Glinge, DY Chiang, M Jouni, F Simonet, SJ Jurgens, ... Nature genetics 54 (3), 232-239, 2022 | 70 | 2022 |
| Hydroquinidine prevents life-threatening arrhythmic events in patients with short QT syndrome A Mazzanti, R Maragna, G Vacanti, A Kostopoulou, M Marino, ... Journal of the American College of Cardiology 70 (24), 3010-3015, 2017 | 69 | 2017 |
| Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome DT Harrell, T Ashihara, T Ishikawa, I Tominaga, A Mazzanti, K Takahashi, ... International journal of cardiology 190, 393-402, 2015 | 69 | 2015 |
Silvia G Priori, MD ,PhDICS Maugeri, IRCCS; Dept Molecular Medicine, Univ of Pavia, Italy -在 fsm.it 的电子邮件经过验证
